stocks logo

CTOR Financial Analysis

Citius Oncology Inc
$
0.664
-0.008(-1.190%)

CTOR Financial Analysis

CTOR Key IndicatorsCTOR Income StatementCTOR Balance SheetCTOR Cash Flow
FY2025Q1FY2024Q4FY2024Q3FY2024Q2FY2024Q1FY2023Q4FY2023Q3FY2023Q2FY2023Q1FY2022Q4FY2022Q3
Total Revenue
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Revenue from Goods & Services
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Gross Profit
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Selling General & Administrative Expenses
6.39M
2282.37%
19.92M
8059.43%
383.96K
-8.90%
383.96K
92.41%
268.43K
81.47%
244.14K
76.77%
421.46K
199.55K
147.92K
138.12K
0.00
Research & Development Expense
1.26M
4.93M
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other Operating Expense - Net
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Operating Profit
-6.39M
2282.37%
-19.92M
8059.43%
-383.96K
-8.90%
-383.96K
92.41%
-268.43K
81.47%
-244.14K
76.77%
-421.46K
-199.55K
-147.92K
-138.12K
0.00
Financing Income- Net
0.00
-100.00%
0.00
-100.00%
636.42K
9.84%
636.42K
-21.99%
758.26K
-0.18%
1.28M
159.11%
579.40K
815.85K
759.65K
493.02K
0.00
Interest Expense
0.00
-100.00%
0.00
-100.00%
-636.42K
9.84%
-636.42K
-21.99%
-758.26K
-0.18%
-1.28M
159.11%
-579.40K
-815.85K
-759.65K
-493.02K
0.00
Other Non-Operating Income
0.00
-1.39M
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Income before Taxes
-6.39M
-1405.55%
-21.32M
-2162.73%
252.46K
59.84%
252.46K
-59.04%
489.83K
-19.93%
1.03M
171.35%
157.94K
616.30K
611.73K
380.81K
0.00
Income Taxes
264.24K
576.00K
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Net Income after Tax
-6.66M
-1459.50%
-21.89M
-2218.47%
252.46K
59.84%
252.46K
-59.04%
489.83K
-19.93%
1.03M
171.35%
157.94K
616.30K
611.73K
380.81K
0.00
Income Available to Common Shares
-6.66M
-1459.50%
-21.89M
-2218.47%
252.46K
59.84%
252.46K
-59.04%
489.83K
-19.93%
1.03M
171.35%
157.94K
616.30K
611.73K
380.81K
0.00
EPS - Basic
-0.09
-228.57%
-0.32
-366.67%
0.04
100.00%
0.04
-42.86%
0.07
0.00%
0.12
200.00%
0.02
0.07
0.07
0.04
0.00
EPS - Diluted
-0.09
-228.57%
-0.32
-366.67%
0.04
100.00%
0.04
-42.86%
0.07
0.00%
0.12
200.00%
0.02
0.07
0.07
0.04
0.00
EBIT
-6.39M
2282.37%
-19.92M
8059.43%
-383.96K
-8.90%
-383.96K
92.41%
-268.43K
81.47%
-244.14K
76.77%
-421.46K
-199.55K
-147.92K
-138.12K
0.00
EBITDA
-6.39M
2282.37%
-19.92M
8059.43%
-383.96K
-8.90%
-383.96K
92.41%
-268.43K
81.47%
-244.14K
76.77%
-421.46K
-199.55K
-147.92K
-138.12K
0.00
Depreciation Depletion & Amortization
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00

CTOR FAQs

What is CTOR's PE Ratio in 2025/4/11?

CTOR's PE ratio in April 11, 2025 is -2.01. This indicates the price investors are willing to pay for $1 of earnings.

What is CTOR's PS Ratio in 2025/4/11?

What is CTOR's Dividend Yield in 2025/Q1?

Free Financial AI Agent for Investment

Ask any investment related question and get answer instantly

Is CTOR earnings result positive or negative?How should I trade on CTOR earnings?